Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Constipation

November 20, 2023 updated by: Shucheng Zhang, Shengjing Hospital

Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Functional Constipation: a Double Blind, Randomized and Placebo-controlled Trial

Constipation is the most common complaint in childhood gastrointestinal disease,affecting an estimated 20% of the global children.The treatment strategies consist of diet control,behavioural intervention and oral and sometimes rectal laxatives. Given higher success rate and fewer side effects,the laxative PEG3350 has been considered the first choice in childhood constipation.However, effectiveness of PEG 3350 laxative is not lasting, additional treatment interventions are still necessary.With an unsatisfactory response to current treatments, many patients seek help from Chinese Herbal Medicine.In view of the traditional theory, childhood constipation is derived from weakness of gastric and splenic function.The functional weakness is characterized by food stagnation and further pathological heat accumulation in the gastrointestine. The food stagnation can slow the gastrointestinal motility while heat causes constipation by drying the intestines and their content. Therefore, the therapeutic principles and practices for childhood constipation must focus on the pathophysiological basis accordingly. In the documented traditional medicine dictionary(Pi Wei Lun), Xiaojidaozhi Decoction is well described in improving the gastric and splenic function, eliminating food stagnation and removing pathological heat accumulation, and it has always been used in treatment of constipation throughout Asia since the first description in Pi Wei Lun in 1249. It comprises twelve herbs. Through the combined action of these herbs, Xiaojidaozhi Decoction can increase fluid in the intestines and facilitate the gastrointestinal motility, relieving the symptoms of constipation. Despite of the long history of successful use of Xiaojidaozhi Decoction in childhood constipation, a large randomized placebo-controlled trial is still not available.The aim of this study was to explore the clinical efficacy and safety of Chinese herbal medicine Xiaojidaozhi Decoction in the treatment of childhood constipation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Liaoning
      • Shenyang, Liaoning, China, 110004
        • Shengjing Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 14 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Clinical diagnosis of childhood constipation
  2. Criteria of constipation meets the Rome IV criteria(H3a)
  3. Must be able to swallow capsules

Exclusion Criteria:

  1. Digestive tract diseases
  2. Neurologic diseases
  3. Endocrine diseases
  4. Metabolic diseases
  5. Gastrointestinal surgery
  6. Using drugs which can take impact on bowl motility

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Xiaojidaozhi Decoction
Xiaojidaozhi Decoction and Fiberform and Toilet training are used for treatment of childhood Constipation
Fiberform is a low-phytate wheat fibre which can increase the gastrointestinal motility.
Toilet training has been considered a routine method in treatment of constipation
Mixture of twelve Chinese herbal medicines granule
Other Names:
  • XJD
Placebo Comparator: non-Xiaojidaozhi Decoction
Placebo and Fiberform and Toilet training are used for treatment of childhood Constipation
Fiberform is a low-phytate wheat fibre which can increase the gastrointestinal motility.
Toilet training has been considered a routine method in treatment of constipation
Mixture of 10% Chinese herbal medicines granule and 90% artificial gum
Other Names:
  • Placebos

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of overall efficacy
Time Frame: week 8(end of treatment)
Efficacy is ranked as cured, improved, same/worse
week 8(end of treatment)
Percentage of overall efficacy
Time Frame: week 20(end of follow-up)
Efficacy is ranked as cured, improved, same/worse
week 20(end of follow-up)
Baseline of constipation score in the beginning of treatment
Time Frame: beginning of treatment(baseline)
Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence
beginning of treatment(baseline)
Change of constipation score from the baseline in the end of treatment
Time Frame: week 8(end of treatment)
Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence
week 8(end of treatment)
Change of constipation score from the baseline in the end of follow-up
Time Frame: week 20(end of follow-up)
Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence
week 20(end of follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Treatment-Emergent Adverse Events
Time Frame: Within week 20(end of follow-up)
The adverse events reported in treatment
Within week 20(end of follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

May 1, 2018

Study Registration Dates

First Submitted

June 4, 2017

First Submitted That Met QC Criteria

June 12, 2017

First Posted (Actual)

June 14, 2017

Study Record Updates

Last Update Posted (Estimated)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 20, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • A333-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constipation

3
Subscribe